GSK Scientists Knew About Zantac's Cancer Risks For Forty Years
By Herman James / February 20, 2023 / marketsanity.com / Article Link
Zero Hedge, Released on 2/20/23
Three years after the Food & Drug Administration (FDA) pulled GSK Plc's heartburn drug Zantac off the market due to suspected links to cancer, and just two weeks before the trial
GSK Scientists Knew About Zantac's Cancer Risks For Forty Years added by Herman James on 02/20/2023View all posts by Herman James ?+'
Recent News
Thor Explorations continues to lead TSXV global gold producers
June 02, 2025 / www.canadianminingreport.com
Gold stocks rise with juniors outperforming majors
June 02, 2025 / www.canadianminingreport.com
Gold Becomes Largest Metals Market
May 26, 2025 / www.canadianminingreport.com
Gold stocks surge on metal gain, Amex boosts Perron resource
May 26, 2025 / www.canadianminingreport.com
Global trade tensions ease and inflation continues to decline
May 19, 2025 / www.canadianminingreport.com